Health-related quality of life in pain-free or mildly symptomatic patients with metastatic hormone-resistant prostate cancer following treatment with the specific endothelin A receptor antagonist zibotentan (ZD4054)

✍ Scribed by Nancy Dawson; Heather Payne; Clare Battersby; Maria Taboada; Nick James

• Publisher: Springer-Verlag
• Year: 2010
• Tongue: English
• Weight: 375 KB
• Volume: 137
• Category: Article
• ISSN: 1432-1335
• DOI: 10.1007/s00432-010-0864-1